UPS to Invest Over $2 Billion in International Healthcare and Supply Chain from 2024 to 2028
UPS announced an investment of more than $2 billion from 2024 to 2028 to expand its international, healthcare, and supply chain solutions businesses. The company will open new hubs in the Philippines (2026), Canada (2027), and Hong Kong (2028), plus a tech-driven center in Taiwan and a facility in Amsterdam. It added weekly flights on Paris–Hong Kong and Shenzhen–Sydney routes, and committed $48 million to build 27 temperature-controlled facilities for healthcare logistics, including GLP-1 drugs.
UPS has announced an investment of more than $2 billion in its international, healthcare, and supply chain solutions businesses over the 2024–2028 period. The company said the move is designed to help businesses improve operational speed and strengthen their resilience against macroeconomic pressures and global supply chain disruptions.
Specific projects covered by the investment include a new hub in the Philippines to be launched in 2026, a facility in Ontario, Canada, in 2027, and a new air hub at Hong Kong International Airport in 2028. In addition, UPS has already activated a technology-driven logistics center in Taiwan and a supply chain facility in Amsterdam that integrates freight, customs brokerage, and cold-chain solutions.
The company has also added air capacity, with Paris–Hong Kong and Shenzhen–Sydney routes each operating five flights per week to meet growing demand. UPS recently announced a $48 million investment to build 27 temperature-controlled facilities across its network, supporting healthcare operations including the transport of temperature-sensitive pharmaceuticals such as GLP-1 drugs.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Logistics & Express Delivery, with intensity 60/100 and 80% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.